• SENSEX 79,310.01
    2,008.61 (+2.60%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,900.00 1,878.00(%)
  • ICICI Bank
    1,501.45 1,479.90(%)
  • ITC
    277.30 252.80(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • M & M
    3,143.95 3,840.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Tonbo Imaging
    1,533.65 1,343.80(%)
  • Tube Investments
    2,310.10 3,335.00(%)
  • TCS
    2,521.00 3,336.70(%)
  • Axis Bank
    1,286.40 1,418.30(%)
  • Aurobindo Pharma
    1,796.95 1,739.95(%)
  • HDFC Life Insur.
    546.20 788.50(%)
  • SBI
    1,009.65 1,234.80(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • P I Industries
    1,749.45 2,006.00(%)
  • Jio Platforms
    1,410.05 1,356.40(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Bajaj Finance
    1,073.70 1,177.60(%)
  • Bharti Airtel
    2,048.00 1,726.05(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bacil Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3688.0
  • ISIN : INE711D01018
17.45 -1 (-3.11%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    17.11

  • Today’s High

    18.86

  • Open

    18.37

  • Perv Close

    18.01

  • 52W Low

    10.65

  • 52W High

    61.80

Key Indicators

  • P/E(TTM)

    39.66

  • Mar.Cap (₹Cr.)

    25.05

  • Div & Yield %

    0.00

  • Book Value(₹)

    17.87

  • Debt-Equity Ratio

    -3.11

  • AGM Date

    04-Nov-2026

  • EPS

    0.44

  • P/E Ratio

    39.66

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    25.05

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    14.35

  • BV (₹)

    17.90

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    1.56

  • NP Var(%)

    1231.0

  • Div%

    0.0

  • CPS (₹)

    1.10

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    25.05

  • 52 Week High

    61.80

  • 52 Week Low

    10.65

  • Price BSE

    17.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    25.05

  • P/C Ratio

    15.70

  • P/E Ratio

    15.70

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 1.24 0.66 0.13 0.11 0.06 0.07
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1.24 0.66 0.13 0.11 0.06 0.07
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.05 0.14 0.10 0.09 0.06 0.05
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.14 0.11 0.08 0.08 0.09 0.08
Miscellaneous Expenses 0.05 0.00 0.00 0.05 3.76 0.17
Employee Benefit Expenses 0.05 0.14 0.10 0.09 0.06 0.05
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.25 0.25 0.19 0.21 3.91 0.30
Operating Profit 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 0.99 0.41 -0.06 -0.10 -3.86 -0.23
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.57 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 1.56 0.40 -0.06 -0.10 -3.86 -0.24
Extraordinary Items 0.00 0.54 0.10 0.05 -3.76 -0.14
Adjusted Net Profit 1.56 -0.14 -0.16 -0.15 -0.10 -0.10
Adjustment below Net Profit -2.17 16.37 0.17 -0.02 3.69 0.24
P & L Balance brought forward 11.46 -5.31 -5.43 -5.30 -5.14 -5.14
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 10.84 11.46 -5.31 -5.43 -5.30 -5.14
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.11 0.29 -0.09 -0.16 -5.91 -0.37
Earnings Per Share(Adj)-Unit Curr 1.11 0.29 -0.09 -0.16 -5.91 -0.37
Book Value 17.76 18.20 1.86 1.68 1.88 2.13
Book Value(Adj)-Unit Curr 17.76 18.20 1.86 1.68 1.88 2.13

Shareholding Pattern

  • Public Share Holding

    100.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,677,150 11.69 1,658,650 22
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 88,717 0.62 15,117 114
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 328,631 2.29 328,631 33
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,941,291 62.30 8,867,291 35
Individuals holding nominal share capital up to Rs. 1 lakh 3,315,175 23.10 1,434,775 7,485
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 200 0.00 200 1
Others 0 0.00 0 0
Sub Total 14,353,000 100.00 12,306,500 7,691
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 14,353,000 100.00 12,306,500 7,691

Company Background

Bacil Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Bacil Pharma Ltd
  • BSE Code : 3688.0
  • ISIN : INE711D01018

  • Incorporation Year

    1987

  • Registered Office

    G2 & G3 Samarpan Complex
    chakala Andheri East, Mumbai,
    Maharashtra-400099

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Tak Bhavana Tak

  • Auditor

    Sarang Shivajirao Chavan & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Bacil Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bacil Pharma 17.45 1.24 0.00 39.66 3.93
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77